Search Results

Displaying Results 1-1 of 1 "'PRLD'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - <em>PRLD</em>

Nov 20, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated - PRLD

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prelude Therapeutics Incorporated ("Prelude" or the "Company") (NASDAQ: PRLD). Such investors are advised to contact Danielle Peyton at [email protected] or

More news about: Pomerantz LLP

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.